Crispr-Cas System: A Promising Diagnostic Tool for Covid-19

Crispr-Cas System: A Promising Diagnostic Tool for Covid-19 Publisher

Ebrahimi S¹ ; Khanbabaei H² ; Abbasi S³ ; Fani M⁴ ; Soltani S⁵ ; Zandi M⁵ ; Najafimemar Z⁶

Source: Avicenna Journal of Medical Biotechnology Published:2022

Abstract

More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19. © 2022, Avicenna Journal of Medical Biotechnology. All rights reserved.

Related Docs

View other Related Docs

1. Serological and Molecular Tests for Covid-19: A Recent Update, Iranian Journal of Immunology (2021)

2. Crispr Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential, Cell Proliferation (2025)

3. Modern Diagnostics Processes Among New Strains of Coronaviruses: A Review, Journal of Datta Meghe Institute of Medical Sciences University (2022)

Experts (# of related papers)

View all Related Experts

Samira Rajaei (1)

Mohammad Hossein Nicknam (1)

Style	Citing Format
MLA	Ebrahimi S, et al.. "Crispr-Cas System: A Promising Diagnostic Tool for Covid-19." Avicenna Journal of Medical Biotechnology, vol. 14, no. 1, 2022, pp. 3-9.
APA	Ebrahimi S, Khanbabaei H, Abbasi S, Fani M, Soltani S, Zandi M, Najafimemar Z (2022). Crispr-Cas System: A Promising Diagnostic Tool for Covid-19. Avicenna Journal of Medical Biotechnology, 14(1), 3-9.
Chicago	Ebrahimi S, Khanbabaei H, Abbasi S, Fani M, Soltani S, Zandi M, Najafimemar Z. "Crispr-Cas System: A Promising Diagnostic Tool for Covid-19." Avicenna Journal of Medical Biotechnology 14, no. 1 (2022): 3-9.
Harvard	Ebrahimi S et al. (2022) 'Crispr-Cas System: A Promising Diagnostic Tool for Covid-19', Avicenna Journal of Medical Biotechnology, 14(1), pp. 3-9.
Vancouver	Ebrahimi S, Khanbabaei H, Abbasi S, Fani M, Soltani S, Zandi M, et al.. Crispr-Cas System: A Promising Diagnostic Tool for Covid-19. Avicenna Journal of Medical Biotechnology. 2022;14(1):3-9.
BibTex	@article{ author = {Ebrahimi S and Khanbabaei H and Abbasi S and Fani M and Soltani S and Zandi M and Najafimemar Z}, title = {Crispr-Cas System: A Promising Diagnostic Tool for Covid-19}, journal = {Avicenna Journal of Medical Biotechnology}, volume = {14}, number = {1}, pages = {3-9}, year = {2022} }
RIS	TY - JOUR AU - Ebrahimi S AU - Khanbabaei H AU - Abbasi S AU - Fani M AU - Soltani S AU - Zandi M AU - Najafimemar Z TI - Crispr-Cas System: A Promising Diagnostic Tool for Covid-19 JO - Avicenna Journal of Medical Biotechnology VL - 14 IS - 1 SP - 3 EP - 9 PY - 2022 ER -

Science Communicator Platform

Authors

Abstract